Yarrow Bioscience Inc (YARW) — Financial Flexibility Index
Yarrow Bioscience Inc (YARW) has a Financial Flexibility Index of -3.30x as of March 2026. Free cash flow of $-4.08 Million (operating CF $-4.08 Million minus capex $0.00) represents -3% of total liabilities ($1.24 Million). See Yarrow Bioscience Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Yarrow Bioscience Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Yarrow Bioscience Inc across 11 annual periods. Check YARW capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Financial Flexibility Index for Yarrow Bioscience Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Yarrow Bioscience Inc. For the full cash flow conversion analysis, see Yarrow Bioscience Inc (YARW) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -13.83x | $-33.12 Million | $-33.12 Million | $2.40 Million | ▼ -505.4% |
| 2024 | -2.28x | $-33.85 Million | $-33.97 Million | $14.82 Million | ▲ +19.3% |
| 2023 | -2.83x | $-25.34 Million | $-25.34 Million | $8.95 Million | ▲ +7.3% |
| 2022 | -3.06x | $-29.20 Million | $-29.20 Million | $9.56 Million | ▲ +0.2% |
| 2021 | -3.06x | $-56.37 Million | $-56.37 Million | $18.41 Million | ▼ -25.7% |
| 2020 | -2.44x | $-136.97 Million | $-137.08 Million | $56.25 Million | ▲ +60.1% |
| 2019 | -6.11x | $-65.09 Million | $-65.10 Million | $10.66 Million | ▼ -10.9% |
| 2018 | -5.51x | $-52.59 Million | $-52.73 Million | $9.55 Million | ▼ -2317.7% |
| 2017 | -0.23x | $-28.22 Million | $-28.25 Million | $123.90 Million | ▼ -620.5% |
| 2016 | -0.03x | $-2.26 Million | $-2.29 Million | $71.49 Million | ▲ +54.8% |
| 2015 | -0.07x | $-4.18 Million | $-4.18 Million | $59.84 Million | — |